Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novo A/s
Relationship:   10% Owner
City:   Bagsvaerd
State:   G7
   
Insider Summary:
  
   
Companies Owned :   42    
Direct Shares   92,467,944    

Indirect Shares

   0      
Direct Value   $748,040,512    

Indirect Value

   $0      
Total Shares   92,467,944      
Total Value   $748,040,512      


Inogen Inc $17,591,047 Flexion Therapeutics Inc $19,454,155 Akebia Therapeutics, Inc. $1,834,828 Alder Biopharmaceuticals Inc $60,438,335 Zs Pharma, Inc. $0 Otonomy, Inc. $0 Nevro Corp $21,487,493 Tobira Therapeutics Inc $0 Colucid Pharmaceuticals, Inc. $0 Corvus Pharmaceuticals, Inc. $2,890,156 Reata Pharmaceuticals Inc $102,173,974 Irhythm Technologies, Inc. $210,341,596 Ra Pharmaceuticals, Inc. $95,402,152 Apollo Endosurgery, Inc $13,018,420 Anaptysbio Inc $45,335,900 Entasis Therapeutics Holdings Inc. $4,778,236 Milestone Pharmaceuticals Inc. $0 Morphic Holding, Inc. $75,712,665 Mirum Pharmaceuticals, Inc. $0 Galera Therapeutics, Inc. $433,034 Nkarta, Inc. $0 Inozyme Pharma, Inc. $0 Checkmate Pharmaceuticals, Inc. $22,700,895 Harmony Biosciences Holdings, Inc. $0 Spruce Biosciences, Inc. $0 Praxis Precision Medicines, Inc. $0 Aligos Therapeutics, Inc. $0 Eargo, Inc. $0 Galecto Inc. $0 Bolt Biotherapeutics, Inc. $4,667,029 Edgewise Therapeutics, Inc. $0 Reneo Pharmaceuticals, Inc. $6,027,910 Cyteir Therapeutics, Inc. $10,636,851 Verve Therapeutics, Inc. $0 Minerva Surgical Inc $0 Io Biotech, Inc. $0 Arcellx, Inc. $0 Disc Medicine, Inc $33,115,838 Metagenomi, Inc. $0 Inogen Inc $17,591,047 Flexion Therapeutics Inc $19,454,155 Akebia Therapeutics, Inc. $1,834,828 Alder Biopharmaceuticals Inc $60,438,335 Zs Pharma, Inc. $0 Otonomy, Inc. $0 Nevro Corp $21,487,493 Tobira Therapeutics Inc $0 Colucid Pharmaceuticals, Inc. $0 Corvus Pharmaceuticals, Inc. $2,890,156 Reata Pharmaceuticals Inc $102,173,974 Irhythm Technologies, Inc. $210,341,596 Ra Pharmaceuticals, Inc. $95,402,152 Apollo Endosurgery, Inc $13,018,420 Anaptysbio Inc $45,335,900 Entasis Therapeutics Holdings Inc. $4,778,236 Milestone Pharmaceuticals Inc. $0 Morphic Holding, Inc. $75,712,665 Mirum Pharmaceuticals, Inc. $0 Galera Therapeutics, Inc. $433,034 Nkarta, Inc. $0 Inozyme Pharma, Inc. $0 Checkmate Pharmaceuticals, Inc. $22,700,895 Harmony Biosciences Holdings, Inc. $0 Spruce Biosciences, Inc. $0 Praxis Precision Medicines, Inc. $0 Aligos Therapeutics, Inc. $0 Eargo, Inc. $0 Galecto Inc. $0 Bolt Biotherapeutics, Inc. $4,667,029 Edgewise Therapeutics, Inc. $0 Reneo Pharmaceuticals, Inc. $6,027,910 Cyteir Therapeutics, Inc. $10,636,851 Verve Therapeutics, Inc. $0 Minerva Surgical Inc $0 Io Biotech, Inc. $0 Arcellx, Inc. $0 Disc Medicine, Inc $33,115,838 Metagenomi, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    26    

     Stock price went up :
    0   
    14    
     Stock price went down :
    4   
    12    
   
     Gain/Loss Ratio :
   -4.0   
   1.2   
     Percentage Gain/Loss :
   -55.1%
 -223.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomimetic Therapeutics, Inc. BMTI 10% Owner 2013-03-01 0 2006-05-11 0    Premium*  
            Iveric Bio Inc ISEE 10% Owner 2016-12-15 0 2013-09-30 0    Premium*  
            Inogen Inc INGN 10% Owner 2021-06-02 2,079,320 0    Premium*  
            Flexion Therapeutics Inc FLXN 10% Owner 2015-06-22 2,133,131 2014-02-18 0    Premium*  
            Akebia Therapeutics, Inc. AKBA SEE REMARKS, 10% Owner 2014-03-25 1,516,387 2014-03-25 0    Premium*  
            Alder Biopharmaceuticals Inc ALDR SEE REMARKS, 10% Owner 2014-05-13 3,201,183 2014-05-13 0    Premium*  
            Zs Pharma, Inc. ZSPH See Remarks, 10% Owner 2014-06-23 781,730 2014-06-23 0    Premium*  
            Otonomy, Inc. OTIC SEE REMARKS, 10% Owner 2014-08-19 2,175,025 2014-08-18 0    Premium*  
            Nevro Corp NVRO SEE REMARKS, 10% Owner 2014-11-12 2,194,841 2014-11-12 0    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-07-13 1,875,905 2015-05-04 0    Premium*  
            Htg Molecular Diagnostics, Inc HTGM 10% Owner 2017-08-25 0 2015-05-11 0    Premium*  
            Colucid Pharmaceuticals, Inc. CLCD 10% Owner 2016-09-09 3,156,563 2015-05-11 0    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS 10% Owner 2020-07-08 1,389,498 2016-03-29 0    Premium*  
            Reata Pharmaceuticals Inc RETA 10% Owner 2017-06-14 592,794 2016-06-01 0    Premium*  
            Irhythm Technologies, Inc. IRTC 10% Owner 2016-10-25 2,124,448 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 2,031,562 2016-10-31 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV 10% Owner 2017-10-12 0 0    Premium*  
            Apollo Endosurgery, Inc APEN 10% Owner 2017-07-26 1,301,842 0    Premium*  
            Anaptysbio Inc ANAB 10% Owner 2017-08-21 1,936,604 2017-01-31 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 2,181,843 2018-09-28 0    Premium*  
            Milestone Pharmaceuticals Inc. MIST 10% Owner 2019-05-13 2,674,470 2019-05-13 0    Premium*  
            Morphic Holding, Inc. MORF 10% Owner 2019-06-28 2,645,446 2019-06-28 0    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 2,445,147 2019-07-22 0    Premium*  
            Galera Therapeutics, Inc. GRTX 10% Owner 2021-02-18 2,459,021 2019-11-12 0    Premium*  
            Nkarta, Inc. NKTX 10% Owner 2020-07-14 2,793,865 2020-07-14 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2021-01-28 2,194,379 2020-07-28 0    Premium*  
            Checkmate Pharmaceuticals, Inc. CMPI 10% Owner 2022-02-25 2,161,990 2020-08-11 0    Premium*  
            Harmony Biosciences Holdings, Inc. HRMY 10% Owner 2020-08-21 3,754,973 2020-08-21 0    Premium*  
            Spruce Biosciences, Inc. SPRB 10% Owner 2024-03-21 2,550,000 2020-10-14 0    Premium*  
            Praxis Precision Medicines, Inc. PRAX 10% Owner 2020-10-20 2,442,080 2020-10-20 0    Premium*  
            Aligos Therapeutics, Inc. ALGS 10% Owner 2020-10-20 2,614,563 2020-10-20 0    Premium*  
            Eargo, Inc. EAR 10% Owner 2020-10-20 887,071 2020-10-20 0    Premium*  
            Galecto Inc. GLTO 10% Owner 2020-11-02 2,497,791 2020-11-02 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2022-07-13 3,703,991 0    Premium*  
            Edgewise Therapeutics, Inc. EWTX 10% Owner 2022-09-14 6,071,703 2021-03-30 0    Premium*  
            Reneo Pharmaceuticals, Inc. RPHM 10% Owner 2023-06-23 3,330,337 2021-04-13 0    Premium*  
            Cyteir Therapeutics, Inc. CYT 10% Owner 2023-07-20 3,522,136 2021-06-22 0    Premium*  
            Verve Therapeutics, Inc. VERV 10% Owner 2021-06-21 793,265 2021-06-21 0    Premium*  
            Minerva Surgical Inc UTRS 10% Owner 2021-10-26 2,057,132 2021-10-26 0    Premium*  
            Io Biotech, Inc. IOBT 10% Owner 2024-02-09 5,088,258 2021-11-09 0    Premium*  
            Arcellx, Inc. ACLX 10% Owner 2022-02-08 4,016,878 2022-02-08 0    Premium*  
            Disc Medicine, Inc IRON 10% Owner 2023-06-28 1,090,772 0    Premium*  
* Premium Members only  

Records found :    234         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 10
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACLX Arcellx, Inc. 10% Owner   –       –       •   2022-02-08 4 B $15.00 $12,499,995 D/D 833,333 4,016,878 2.45 -
ACLX Arcellx, Inc. 10% Owner   –       –       •   2022-02-08 4 A $0.00 $0 D/D 3,183,545 3,183,545 0 -
AKBA Akebia Therapeutics, Inc. SEE REMARKS   –       –       •   2014-03-25 4 B $17.00 $3,104,030 D/D 182,590 1,516,387 2.45 -
AKBA Akebia Therapeutics, Inc. SEE REMARKS   –       –       •   2014-03-25 4 A $0.00 $0 D/D 1,333,797 1,333,797 0 -
ALDR Alder Biopharmaceuticals ... SEE REMARKS   –       –       •   2014-05-13 4 A $0.00 $0 D/D 2,651,183 2,651,183 0 -
ALDR Alder Biopharmaceuticals ... SEE REMARKS   –       –       •   2014-05-13 4 B $10.00 $5,500,000 D/D 550,000 3,201,183 2.45 -
ALGS Aligos Therapeutics, Inc. 10% Owner   –       –       •   2020-10-20 4 B $15.00 $3,000,000 D/D 200,000 2,614,563 2.45 -
ALGS Aligos Therapeutics, Inc. 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 D/D 2,414,563 2,414,563 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 OE $0.00 $0 D/D 81,673 2,983,504 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 A $0.00 $0 D/D 2,901,831 2,901,831 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 B $15.00 $750,000 D/D 50,000 3,033,504 2.45 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-01 4 S $23.87 $562,270 D/D (23,555) 3,009,949 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-02 4 S $23.87 $613,485 D/D (25,700) 2,984,249 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-03 4 S $22.01 $472,192 D/D (21,451) 2,962,798 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-04 4 S $22.00 $225,963 D/D (10,271) 2,952,527 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-07 4 S $21.10 $10,151,443 D/D (481,023) 2,471,504 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-14 4 S $21.79 $766,493 D/D (35,172) 2,436,332 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-15 4 S $21.00 $3,011,988 D/D (143,428) 2,292,904 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-08-21 4 S $21.10 $7,518,251 D/D (356,300) 1,936,604 0 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2016-12-29 3 IO $0.00 $0 D/D 0 1,456,972 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2017-05-10 4 S $5.74 $8,609 D/D (1,500) 1,455,472 0 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2017-05-11 4 S $5.62 $582,094 D/D (103,500) 1,351,972 0 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2017-07-24 4 S $6.83 $117,538 D/D (17,200) 1,334,772 0 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2017-07-25 4 S $6.96 $170,585 D/D (24,504) 1,310,268 0 -
APEN Apollo Endosurgery, Inc 10% Owner   –       –       •   2017-07-26 4 S $6.84 $57,643 D/D (8,426) 1,301,842 0 -
  234  Records found
  1  2   3   4   5   6   7   8   9   10      
  Page 1 of 10  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us